Congress Calendar


Thursday 3.09.2015

  • 18.05.2015 »

    Endo announced Monday a definitive agreement to acquire Par Pharmaceutical from private-equity firm TPG under a transaction valued at $8.05 billion, expanding its generics business. Endo CEO Rajiv De Silva remarked that the deal “builds upon our generics growth, adding a strong portfolio of high barrier-to-entry and attractive gross margin products while also transforming Endo, [...]

  • 30.03.2015 »

    The Wall Street Journal (2/20, Beckerman, Subscription Publication) reported that the FDA has approved the VenaSeal system from Medtronic PLC to treat varicose veins. The system works by dealing the veins with an adhesive, and is approved for patients suffering from varicose veins of the legs that cause blood clots, pain, or other symptoms. The [...]

  • 23.02.2015 »

    Contributor Arlene Weintraub wrote in Forbes (2/20) that according to a new study published online in the journal Menopause, “a staggering 86% of women don’t understand that products sold by compounding pharmacies are not approved by” the FDA, despite an “estimated 28 million to 39 million prescriptions are filled each year for hormone-replacement therapies made [...]

  • 18.02.2015 »

    In a 3,100-word story, the second in a series of articles, the Arizona Republic (2/18, Alltucker) reports how researchers from the Alzheimer’s Prevention Initiative “assembled a panel of experts to evaluate about 20 anti-amyloid drugs in various levels of development before settling on one called crenezumab” to test in people in Colombia who suffer from [...]

  • 14.01.2015 »

    NPR (1/14) reports in its “Shots” blog that an analysis in “the American Medical Association’s flagship journal JAMA” shows the United States funds 44 percent of the world’s biomedical research, a drop from 57 percent a decade ago. Hamilton Moses III, MD, founder of Alerion Advisors and one of the five co-authors of the paper, [...]